Danisco A/S appeared to be the Corporate Investor, which was created in 1989. The leading representative office of defined Corporate Investor is situated in the Copenhagen. The company was established in Europe in Denmark.
Among the most successful fund investment fields, there are Health Care, Food and Beverage. Among the most popular portfolio startups of the fund, we may highlight Hyglos, Redpoint Bio. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany.
The common things for fund are deals in the range of 10 - 50 millions dollars. This Danisco A/S works on 71 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2005. The top amount of exits for fund were in 2016. The fund is constantly included in less than 2 deals per year.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Danisco A/S, startups are often financed by Techno Venture Management, Sanders Morris Harris, Mulligan BioCapital. The meaningful sponsors for the fund in investment in the same round are TVM Capital, Signet Healthcare Partners, RK Ventures Group. In the next rounds fund is usually obtained by TVM Capital, NRW.BANK.
|EastWest VentureGroup||United States, Los Angeles|
|International Biotechnology Trust||United Kingdom, London|
|KCK||United States, New York|
|Accelerator Life Science Partners||-|
|Thompson Street Capital Partners||United States, St Louis|
|Jiangxing Shiye||China, Futian|
|Southern Raytai Group||-|
|Jiesi Hanneng||China, Huangpu|
|Shenzhen Riwei Investment||China, Shenzhen|
DIREVO Industrial Biotechnology
|$16M||18 Oct 2007||Germany, Cologne|
|$9M||23 Aug 2005||Germany, Bernried|
|$10M||13 Nov 2003||United States, " United States"}|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.